David Brachman

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Robert Jeraj, Maria Werner-Wasik, Deborah T Blumenthal, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Peter Nakaji, Nader Sanai, Kris A. Smith, 2014, Journal of neurosurgery.

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.

Maria Werner-Wasik, Lucia Zamorano, Walter J Curran, 2004, International journal of radiation oncology, biology, physics.

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

Walter Curran, Luis Souhami, B. Scheithauer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Walter J. Curran, Mark R. Gilbert, Jean-Paul Bahary, 2016, The New England journal of medicine.